Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 77.01 K201.3 K113.56 K107.69 K 499.56 K Research & development ———— — Operating income -77.01 K-274.85 K-203.56 K-197.69 K -753.11 K Non-Operating Income, Total 0905.15 K1.74 M1.58 M 4.23 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 0905.15 K1.74 M1.58 M 4.23 M Unusual income/expense ———— — Pretax income -77.01 K630.31 K1.54 M1.39 M 3.47 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -77.01 K630.31 K1.54 M1.39 M 3.47 M Discontinued operations ———— — Net income -77.01 K630.31 K1.54 M1.39 M 3.47 M Dilution adjustment ———177.56 M — Preferred dividends ———177.56 M — Diluted net income available to common stockholders -77.01 K630.31 K1.54 M1.39 M 3.47 M Basic earnings per share (Basic EPS) 0.010.030.090.06 0.19 Diluted earnings per share (Diluted EPS) 0.010.030.090.06 0.19 Average basic shares outstanding 5 M186.89 K274.91 K450 K — Diluted shares outstanding 5 M186.89 K274.91 K450 K — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —